Join us for a 2-day multi-disciplinary course on establishing the validity and utility of genomic applications in clinical and preventive medicine on August 15-16, 2013 at Emory University, Atlanta, GA
What can genomic medicine offer today?
How can genomics improve screening and prevention of disease?
When can pharmacogenetic testing be used to guide drug treatment?
When are genomic tests useful for risk prediction?
What research is needed to improve translation of genomic research?
What level of evidence is needed for evidence-based genomic medicine?
Genomic research is moving at a breathtaking pace and low-cost sequencing will be available within a few years. A major challenge for the next decade is to determine when and how genomic information can be usefully applied in clinical and public health practice. What determines the predictive ability of genomic information? And when is genomic testing useful for improving the health of individuals or populations? Researchers, healthcare providers, policy makers, and medical and public health professionals all have an interest in identifying the added value of genomic information for health care. This 2-day course will explore a multi-disciplinary approach to establishing the validity and utility of genomic applications in clinical and preventive medicine.
A Two-day Course
The course will detail a systematic approach for evaluating the evidence on the validity and utility of genomic health applications, such as the one developed by Evaluation of Genomic Application in Practice and Prevention Project. This approach addresses the following key topics:
- Defining the disorder and setting: what test is offered to whom for what purpose?
- Assessing analytic validity: does the test measure what it intends to measure?
- Assessing clinical validity: what is the predictive ability of the test?
- Assessing clinical utility: what is the impact of genetic testing? Does it improve health outcomes?
- Considering contextual issues: what are the behavioral, ethical, legal, or social implications of using the test? What is known about its comparative effectiveness and cost-effectiveness?
A. Cecile J.W. Janssens, PhD, Department of Epidemiology, Emory University, Atlanta GA
Muin J. Khoury, MD, PhD, Office of Public Health Genomics, CDC, Atlanta GA
Marta Gwinn, MD, MPH, Office of Public Health Genomics, CDC, Atlanta GA
Cecelia Bellcross, PhD, MS, CGC, Department of Human Genetics, Emory University, Atlanta GA
Click here for a printable pdf flyer for this event.